Your browser doesn't support javascript.
loading
Proactive strategies to optimize engagement of Black, Hispanic/Latinx, transgender, and nonbinary individuals in a trial of a novel agent for HIV pre-exposure prophylaxis (PrEP).
Cespedes, Michelle; Das, Moupali; Hojilla, J Carlo; Blumenthal, Jill; Mounzer, Karam; Ramgopal, Moti; Hodge, Theo; Torres, Thiago S; Peterson, Charles; Shibase, Senzokuhle; Elliott, Ayana; Demidont, A C; Callaghan, Larkin; Watson, C Chauncey; Carter, Christoph; Kintu, Alex; Baeten, Jared M; Ogbuagu, Onyema.
Afiliación
  • Cespedes M; Division of Infectious Disease, Icahn School of Medicine at Mount Sinai, New York, NY, United States of America.
  • Das M; Gilead Sciences, Foster City, CA, United States of America.
  • Hojilla JC; Gilead Sciences, Foster City, CA, United States of America.
  • Blumenthal J; Department of Medicine, University of California San Diego, San Diego, CA, United States of America.
  • Mounzer K; Philadelphia FIGHT Community Health Centers, Philadelphia, PA, United States of America.
  • Ramgopal M; Midway Research Center, Fort Pierce, FL, United States of America.
  • Hodge T; Washington Health Institute, Washington, DC, United States of America.
  • Torres TS; Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.
  • Peterson C; Department of Medicine, College of Medicine, University of Illinois Chicago, Chicago, IL, United States of America.
  • Shibase S; National LGBTI Health Campaign, Johannesburg, South Africa.
  • Elliott A; Gilead Sciences, Foster City, CA, United States of America.
  • Demidont AC; Gilead Sciences, Foster City, CA, United States of America.
  • Callaghan L; Gilead Sciences, Foster City, CA, United States of America.
  • Watson CC; Gilead Sciences, Foster City, CA, United States of America.
  • Carter C; Gilead Sciences, Foster City, CA, United States of America.
  • Kintu A; Gilead Sciences, Foster City, CA, United States of America.
  • Baeten JM; Gilead Sciences, Foster City, CA, United States of America.
  • Ogbuagu O; Department of Internal Medicine, Section of Infectious Diseases, Yale School of Medicine, New Haven, CT, United States of America.
PLoS One ; 17(6): e0267780, 2022.
Article en En | MEDLINE | ID: mdl-35657826
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Infecciones por VIH / Fármacos Anti-VIH / Personas Transgénero / Profilaxis Pre-Exposición / Minorías Sexuales y de Género Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies Límite: Adolescent / Female / Humans / Male Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Infecciones por VIH / Fármacos Anti-VIH / Personas Transgénero / Profilaxis Pre-Exposición / Minorías Sexuales y de Género Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies Límite: Adolescent / Female / Humans / Male Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos